VHL loss causes spindle misorientation and chromosome instability

Area of Science:

• Cell Biology
• Genetics
• Cancer Research

Background:

• Mitotic fidelity is essential for preventing genomic instability and tumorigenesis.
• The von Hippel-Lindau (VHL) tumor suppressor protein (pVHL) is frequently inactivated in renal cell carcinoma.
• The precise role of pVHL in mitosis and its connection to cancer remains incompletely understood.

Purpose of the Study:

• To investigate the role of pVHL in mitotic spindle function and chromosomal stability.
• To determine the mechanism by which pVHL inactivation leads to genomic instability.
• To explore the therapeutic implications of pVHL's function in tumor suppression.

Main Methods:

• Immunofluorescence microscopy to determine pVHL localization during mitosis.
• Analysis of spindle orientation and checkpoint function in VHL-deficient cells.
• Western blotting to assess Mad2 protein levels.
• Rescue experiments with wild-type pVHL or Mad2 in VHL-defective cells.
• Correlation analysis in human renal cancer samples.

Main Results:

• pVHL localizes to the mitotic spindle in mammalian cells.
• pVHL inactivation causes spindle misorientation, weakened spindle checkpoint, and chromosomal instability.
• Spindle misorientation is linked to astral microtubule instability and is rescued by functional pVHL.
• Chromosomal instability and checkpoint defects result from reduced Mad2 levels due to pVHL inactivation.
• pVHL re-expression or Mad2 re-expression rescues these defects in VHL-defective cells.
• VHL inactivation, reduced Mad2 levels, and aneuploidy are associated in human renal cancer.

Conclusions:

• pVHL plays a critical role in maintaining mitotic spindle orientation and chromosomal stability.
• pVHL inactivation contributes to tumorigenesis through impaired spindle function and genomic instability, partly via regulation of Mad2.
• These findings highlight novel tumor suppressive functions of pVHL and suggest potential therapeutic strategies for VHL-related cancers.